Trial Profile
Comparison of insulin detemir and insulin glargine in patients with Type 2 diabetes.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Jun 2019
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary) ; Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 19 Jun 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database
- 17 May 2011 New trial record